世界の神経因性疼痛治療​​薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neuropathic Pain Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4572 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、神経因性疼痛治療​​薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗けいれん薬、抗うつ薬、NSAID、オピオイド、ステロイド、その他）、用途別市場規模（糖尿病性ニューロパチー、化学療法による神経障害性疼痛、帯状疱疹後神経痛、脊髄損傷、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・神経因性疼痛治療​​薬の市場動向 ・企業の競争状況、市場シェア ・神経因性疼痛治療​​薬の種類別市場規模と予測2016-2027（抗けいれん薬、抗うつ薬、NSAID、オピオイド、ステロイド、その他） ・神経因性疼痛治療​​薬の用途別市場規模と予測2016-2027（糖尿病性ニューロパチー、化学療法による神経障害性疼痛、帯状疱疹後神経痛、脊髄損傷、その他） ・神経因性疼痛治療​​薬の北米市場規模2016-2027（アメリカ、カナダ） ・神経因性疼痛治療​​薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経因性疼痛治療​​薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経因性疼痛治療​​薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経因性疼痛治療​​薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis AG、AstraZeneca、GlaxoSmithKline、Eli Lilly and Company、Mallinckrodt Pharmaceuticals、Johnson & Johnson、Abbott、Endo Pharmaceuticals, Inc.、Teva Pharmaceutical Industries Limited、Merck & Co） ・結論

Neuropathic pain therapeutics refers to a way to relieve and treat neuropathic pain through various drugs or treatments. Neuropathic pain is a chronic condition wherein pathological pain continues even after the cause of the pain is eliminated.

Market Analysis and Insights: Global Neuropathic Pain Therapeutics Market
The global Neuropathic Pain Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuropathic Pain Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuropathic Pain Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuropathic Pain Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuropathic Pain Therapeutics market.

Global Neuropathic Pain Therapeutics Scope and Market Size
Neuropathic Pain Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuropathic Pain Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anticonvulsants
Antidepressants
NSAIDs
Opioids
Steroids
Others

Segment by Application
Diabetic Neuropathy
Chemotherapy-Induced Neuropathy Pain
Postherpetic Neuralgia
Spinal Cord Injury
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis AG
AstraZeneca
GlaxoSmithKline
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Abbott
Endo Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited
Merck & Co

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anticonvulsants
1.2.3 Antidepressants
1.2.4 NSAIDs
1.2.5 Opioids
1.2.6 Steroids
1.2.7 Others
1.3 Market by Application
1.3.1 Global Neuropathic Pain Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diabetic Neuropathy
1.3.3 Chemotherapy-Induced Neuropathy Pain
1.3.4 Postherpetic Neuralgia
1.3.5 Spinal Cord Injury
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neuropathic Pain Therapeutics Market Perspective (2016-2027)
2.2 Neuropathic Pain Therapeutics Growth Trends by Regions
2.2.1 Neuropathic Pain Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuropathic Pain Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Neuropathic Pain Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Neuropathic Pain Therapeutics Industry Dynamic
2.3.1 Neuropathic Pain Therapeutics Market Trends
2.3.2 Neuropathic Pain Therapeutics Market Drivers
2.3.3 Neuropathic Pain Therapeutics Market Challenges
2.3.4 Neuropathic Pain Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neuropathic Pain Therapeutics Players by Revenue
3.1.1 Global Top Neuropathic Pain Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Neuropathic Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuropathic Pain Therapeutics Revenue
3.4 Global Neuropathic Pain Therapeutics Market Concentration Ratio
3.4.1 Global Neuropathic Pain Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Therapeutics Revenue in 2020
3.5 Neuropathic Pain Therapeutics Key Players Head office and Area Served
3.6 Key Players Neuropathic Pain Therapeutics Product Solution and Service
3.7 Date of Enter into Neuropathic Pain Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropathic Pain Therapeutics Breakdown Data by Type
4.1 Global Neuropathic Pain Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2022-2027)

5 Neuropathic Pain Therapeutics Breakdown Data by Application
5.1 Global Neuropathic Pain Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neuropathic Pain Therapeutics Market Size (2016-2027)
6.2 North America Neuropathic Pain Therapeutics Market Size by Type
6.2.1 North America Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
6.3 North America Neuropathic Pain Therapeutics Market Size by Application
6.3.1 North America Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
6.4 North America Neuropathic Pain Therapeutics Market Size by Country
6.4.1 North America Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neuropathic Pain Therapeutics Market Size (2016-2027)
7.2 Europe Neuropathic Pain Therapeutics Market Size by Type
7.2.1 Europe Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
7.3 Europe Neuropathic Pain Therapeutics Market Size by Application
7.3.1 Europe Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
7.4 Europe Neuropathic Pain Therapeutics Market Size by Country
7.4.1 Europe Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type
8.2.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application
8.3.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region
8.4.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neuropathic Pain Therapeutics Market Size (2016-2027)
9.2 Latin America Neuropathic Pain Therapeutics Market Size by Type
9.2.1 Latin America Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Neuropathic Pain Therapeutics Market Size by Application
9.3.1 Latin America Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Neuropathic Pain Therapeutics Market Size by Country
9.4.1 Latin America Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type
10.2.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application
10.3.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country
10.4.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Neuropathic Pain Therapeutics Introduction
11.1.4 Pfizer Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Neuropathic Pain Therapeutics Introduction
11.2.4 Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Neuropathic Pain Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Introduction
11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Introduction
11.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Mallinckrodt Pharmaceuticals
11.6.1 Mallinckrodt Pharmaceuticals Company Details
11.6.2 Mallinckrodt Pharmaceuticals Business Overview
11.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Introduction
11.6.4 Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.6.5 Mallinckrodt Pharmaceuticals Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Introduction
11.7.4 Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Abbott
11.8.1 Abbott Company Details
11.8.2 Abbott Business Overview
11.8.3 Abbott Neuropathic Pain Therapeutics Introduction
11.8.4 Abbott Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.8.5 Abbott Recent Development
11.9 Endo Pharmaceuticals, Inc.
11.9.1 Endo Pharmaceuticals, Inc. Company Details
11.9.2 Endo Pharmaceuticals, Inc. Business Overview
11.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Introduction
11.9.4 Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.9.5 Endo Pharmaceuticals, Inc. Recent Development
11.10 Teva Pharmaceutical Industries Limited
11.10.1 Teva Pharmaceutical Industries Limited Company Details
11.10.2 Teva Pharmaceutical Industries Limited Business Overview
11.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Introduction
11.10.4 Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Limited Recent Development
11.11 Merck & Co
11.11.1 Merck & Co Company Details
11.11.2 Merck & Co Business Overview
11.11.3 Merck & Co Neuropathic Pain Therapeutics Introduction
11.11.4 Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2016-2021)
11.11.5 Merck & Co Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anticonvulsants
Table 3. Key Players of Antidepressants
Table 4. Key Players of NSAIDs
Table 5. Key Players of Opioids
Table 6. Key Players of Steroids
Table 7. Key Players of Others
Table 8. Global Neuropathic Pain Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Neuropathic Pain Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Neuropathic Pain Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Neuropathic Pain Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Neuropathic Pain Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Neuropathic Pain Therapeutics Market Share by Regions (2022-2027)
Table 14. Neuropathic Pain Therapeutics Market Trends
Table 15. Neuropathic Pain Therapeutics Market Drivers
Table 16. Neuropathic Pain Therapeutics Market Challenges
Table 17. Neuropathic Pain Therapeutics Market Restraints
Table 18. Global Neuropathic Pain Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Neuropathic Pain Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Neuropathic Pain Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Therapeutics as of 2020)
Table 21. Ranking of Global Top Neuropathic Pain Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Neuropathic Pain Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Neuropathic Pain Therapeutics Product Solution and Service
Table 25. Date of Enter into Neuropathic Pain Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Neuropathic Pain Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Neuropathic Pain Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Neuropathic Pain Therapeutics Product
Table 68. Pfizer Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Novartis AG Company Details
Table 71. Novartis AG Business Overview
Table 72. Novartis AG Neuropathic Pain Therapeutics Product
Table 73. Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Novartis AG Recent Development
Table 75. AstraZeneca Company Details
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca Neuropathic Pain Therapeutics Product
Table 78. AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 79. AstraZeneca Recent Development
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Neuropathic Pain Therapeutics Product
Table 83. GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 84. GlaxoSmithKline Recent Development
Table 85. Eli Lilly and Company Company Details
Table 86. Eli Lilly and Company Business Overview
Table 87. Eli Lilly and Company Neuropathic Pain Therapeutics Product
Table 88. Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Eli Lilly and Company Recent Development
Table 90. Mallinckrodt Pharmaceuticals Company Details
Table 91. Mallinckrodt Pharmaceuticals Business Overview
Table 92. Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Product
Table 93. Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Mallinckrodt Pharmaceuticals Recent Development
Table 95. Johnson & Johnson Company Details
Table 96. Johnson & Johnson Business Overview
Table 97. Johnson & Johnson Neuropathic Pain Therapeutics Product
Table 98. Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Johnson & Johnson Recent Development
Table 100. Abbott Company Details
Table 101. Abbott Business Overview
Table 102. Abbott Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Abbott Recent Development
Table 104. Endo Pharmaceuticals, Inc. Company Details
Table 105. Endo Pharmaceuticals, Inc. Business Overview
Table 106. Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Product
Table 107. Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Endo Pharmaceuticals, Inc. Recent Development
Table 109. Teva Pharmaceutical Industries Limited Company Details
Table 110. Teva Pharmaceutical Industries Limited Business Overview
Table 111. Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Product
Table 112. Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Teva Pharmaceutical Industries Limited Recent Development
Table 114. Merck & Co Company Details
Table 115. Merck & Co Business Overview
Table 116. Merck & Co Neuropathic Pain Therapeutics Product
Table 117. Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2016-2021) & (US$ Million)
Table 118. Merck & Co Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuropathic Pain Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Anticonvulsants Features
Figure 3. Antidepressants Features
Figure 4. NSAIDs Features
Figure 5. Opioids Features
Figure 6. Steroids Features
Figure 7. Others Features
Figure 8. Global Neuropathic Pain Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Diabetic Neuropathy Case Studies
Figure 10. Chemotherapy-Induced Neuropathy Pain Case Studies
Figure 11. Postherpetic Neuralgia Case Studies
Figure 12. Spinal Cord Injury Case Studies
Figure 13. Others Case Studies
Figure 14. Neuropathic Pain Therapeutics Report Years Considered
Figure 15. Global Neuropathic Pain Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Neuropathic Pain Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Neuropathic Pain Therapeutics Market Share by Regions: 2020 VS 2027
Figure 18. Global Neuropathic Pain Therapeutics Market Share by Regions (2022-2027)
Figure 19. Global Neuropathic Pain Therapeutics Market Share by Players in 2020
Figure 20. Global Top Neuropathic Pain Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropathic Pain Therapeutics as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Neuropathic Pain Therapeutics Revenue in 2020
Figure 22. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2016-2021)
Figure 23. Global Neuropathic Pain Therapeutics Revenue Market Share by Type (2022-2027)
Figure 24. North America Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
Figure 26. North America Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
Figure 27. North America Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
Figure 28. United States Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
Figure 32. Europe Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
Figure 33. Europe Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
Figure 34. Germany Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Neuropathic Pain Therapeutics Market Share by Region (2016-2027)
Figure 44. China Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
Figure 52. Latin America Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
Figure 53. Latin America Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
Figure 54. Mexico Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Neuropathic Pain Therapeutics Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Neuropathic Pain Therapeutics Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Neuropathic Pain Therapeutics Market Share by Country (2016-2027)
Figure 60. Turkey Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Neuropathic Pain Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pfizer Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 64. Novartis AG Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 66. GlaxoSmithKline Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 67. Eli Lilly and Company Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 68. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 70. Abbott Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 71. Endo Pharmaceuticals, Inc. Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 72. Teva Pharmaceutical Industries Limited Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 73. Merck & Co Revenue Growth Rate in Neuropathic Pain Therapeutics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---